These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17238470)

  • 1. Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.
    Bailey TC; Noirot LA; Gage BF; Li X; Shannon WD; Waterman B; Sinha S; Bouselli DA; Reichley RM; Goldberg AC; Dunagan WC
    AMIA Annu Symp Proc; 2006; 2006():850. PubMed ID: 17238470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' knowledge and attitudes about coronary heart disease secondary prevention.
    Pham V; Jeffe DB; Noirot LA; Dunagan WC; Reichley RM; Bailey TC
    AMIA Annu Symp Proc; 2007 Oct; ():1076. PubMed ID: 18694174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
    Garcia BH; Småbrekke L; Trovik T; Giverhaug T
    Eur J Clin Pharmacol; 2013 Mar; 69(3):703-9. PubMed ID: 22990329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' knowledge and attitudes about coronary heart disease prevention guidelines and technology assisted interventions.
    Pham V; Jeffe DB; Noirot LA; Dunagan WC; Reichley RM; Bailey TC
    AMIA Annu Symp Proc; 2005; 2005():1079. PubMed ID: 16779366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention.
    McKinnon PS; Seaton T; Noirot LA; Reichley RM; Heard KM; Shannon WD; Goldberg AC; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2008 Nov; ():868. PubMed ID: 18999065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a mobile phone-based intervention to improve adherence to secondary prevention of coronary heart disease in China.
    Chen S; Gong E; Kazi DS; Gates AB; Karaye KM; Girerd N; Bai R; AlHabib KF; Li C; Sun K; Hong L; Fu H; Peng W; Liu X; Chen L; Schwalm JD; Yan LL
    J Med Eng Technol; 2016; 40(7-8):372-382. PubMed ID: 27686107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness of an automated guideline adherence monitor for secondary prevention of acute myocardial infarction.
    Noirot LA; Hollands JM; Reichley RM; Dunagan WC; Bailey TC
    AMIA Annu Symp Proc; 2007 Oct; ():1061. PubMed ID: 18694159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC; Noirot LA; Blickensderfer A; Rachmiel E; Schaiff R; Kessels A; Braverman A; Goldberg A; Waterman B; Dunagan WC
    Arch Intern Med; 2007 Mar; 167(6):586-90. PubMed ID: 17389290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of secondary prevention guidelines for coronary heart disease: results from a physicians' survey in China.
    Jiang J; Hong T; Yu R; Zhang Y; Liu Z; Huo Y;
    Eur J Prev Cardiol; 2012 Oct; 19(5):991-8. PubMed ID: 21859776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
    Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
    JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus.
    Kamyar M; Johnson BJ; McAnaw JJ; Lemmens-Gruber R; Hudson SA
    Pharm World Sci; 2008 Jan; 30(1):120-7. PubMed ID: 17721698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
    Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
    Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health care quality: medication and prevention in patients with and without coronary heart disease].
    Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
    Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease.
    Garcia BH; Utnes J; Naalsund LU; Giverhaug T
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):249-57. PubMed ID: 21351306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study.
    Vedin O; Hagström E; Stewart R; Brown R; Krug-Gourley S; Davies R; Wallentin L; White H; Held C
    Eur J Prev Cardiol; 2013 Aug; 20(4):678-85. PubMed ID: 22496275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Approaches to Improve Medication Adherence in Patients with Coronary Heart Disease: Progress Towards a Learning Healthcare System.
    Levy AE; Huang C; Huang A; Michael Ho P
    Curr Atheroscler Rep; 2018 Jan; 20(1):5. PubMed ID: 29368179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.
    Edworthy SM; Baptie B; Galvin D; Brant RF; Churchill-Smith T; Manyari D; Belenkie I
    Can J Cardiol; 2007 Nov; 23(13):1066-72. PubMed ID: 17985009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial.
    Park LG; Howie-Esquivel J; Chung ML; Dracup K
    Patient Educ Couns; 2014 Feb; 94(2):261-8. PubMed ID: 24321403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computerized intervention to decrease the use of calcium channel blockers in hypertension.
    Rossi RA; Every NR
    J Gen Intern Med; 1997 Nov; 12(11):672-8. PubMed ID: 9383135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.